Alex West

3.4k total citations · 1 hit paper
38 papers, 622 citations indexed

About

Alex West is a scholar working on Pulmonary and Respiratory Medicine, Critical Care and Intensive Care Medicine and Physiology. According to data from OpenAlex, Alex West has authored 38 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pulmonary and Respiratory Medicine, 7 papers in Critical Care and Intensive Care Medicine and 6 papers in Physiology. Recurrent topics in Alex West's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (17 papers), Pleural and Pulmonary Diseases (15 papers) and Ultrasound in Clinical Applications (6 papers). Alex West is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (17 papers), Pleural and Pulmonary Diseases (15 papers) and Ultrasound in Clinical Applications (6 papers). Alex West collaborates with scholars based in United Kingdom, United States and Australia. Alex West's co-authors include Katherine Myall, Bhashkar Mukherjee, Amy Dewar, Philip L. Molyneaux, Muhunthan Thillai, Rebecca Preston, Giulia Benedetti, Sze Mun Mak, Mark Denton and Thomas Bajanowski and has published in prestigious journals such as CHEST Journal, European Respiratory Journal and Thorax.

In The Last Decade

Alex West

33 papers receiving 606 citations

Hit Papers

Persistent Post–COVID-19 Interstitial Lung Disease. An Ob... 2021 2026 2022 2024 2021 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alex West United Kingdom 12 380 226 172 93 82 38 622
Zhuquan Su China 11 457 1.2× 402 1.8× 293 1.7× 110 1.2× 91 1.1× 32 831
Sze Mun Mak United Kingdom 10 264 0.7× 216 1.0× 185 1.1× 38 0.4× 57 0.7× 23 510
Samanjit S Hare United Kingdom 11 319 0.8× 534 2.4× 297 1.7× 142 1.5× 50 0.6× 19 970
Muhunthan Thillai United Kingdom 13 654 1.7× 235 1.0× 243 1.4× 68 0.7× 102 1.2× 35 965
Atsuyuki Watanabe Japan 11 92 0.2× 185 0.8× 194 1.1× 58 0.6× 54 0.7× 52 537
Eric Derom Belgium 4 159 0.4× 132 0.6× 138 0.8× 67 0.7× 17 0.2× 5 378
Peter Steiger Switzerland 14 73 0.2× 251 1.1× 125 0.7× 77 0.8× 58 0.7× 29 533
Naureen Narula United States 9 65 0.2× 440 1.9× 359 2.1× 50 0.5× 42 0.5× 39 623
Anish R. Mitra Canada 9 61 0.2× 102 0.5× 170 1.0× 80 0.9× 35 0.4× 20 428
Benan Çağlayan Türkiye 13 319 0.8× 44 0.2× 53 0.3× 65 0.7× 108 1.3× 72 559

Countries citing papers authored by Alex West

Since Specialization
Citations

This map shows the geographic impact of Alex West's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex West with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex West more than expected).

Fields of papers citing papers by Alex West

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex West. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex West. The network helps show where Alex West may publish in the future.

Co-authorship network of co-authors of Alex West

This figure shows the co-authorship network connecting the top 25 collaborators of Alex West. A scholar is included among the top collaborators of Alex West based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex West. Alex West is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Edwards, C., et al.. (2025). Home Monitoring in Interstitial Lung Disease: Protocol for a Real-World Observational Study. JMIR Research Protocols. 14. e65339–e65339.
2.
VanFrank, Brenna, Tonya Williams, Iris Alcantara, et al.. (2025). E-Cigarette Use and Symptoms of Depression and Anxiety Among US Middle and High School Students. Preventing Chronic Disease. 22. E51–E51.
3.
Wu, Zhe, Lisa Spencer, Winston Banya, et al.. (2024). Morphine for treatment of cough in idiopathic pulmonary fibrosis (PACIFY COUGH): a prospective, multicentre, randomised, double-blind, placebo-controlled, two-way crossover trial. The Lancet Respiratory Medicine. 12(4). 273–280. 30 indexed citations
4.
West, Alex, Nazia Chaudhuri, Adam Barczyk, et al.. (2023). Inhaled pirfenidone solution (AP01) for IPF: a randomised, open-label, dose–response trial. Thorax. 78(9). 882–889. 35 indexed citations
6.
Myall, Katherine, Alex West, Zhe Wu, et al.. (2023). Nocturnal Hypoxemia Associates With Symptom Progression and Mortality in Patients With Progressive Fibrotic Interstitial Lung Disease. CHEST Journal. 164(5). 1232–1242. 12 indexed citations
7.
Popowicz, Natalia, Francesco Lo Piccolo, Cindy Yeoh, et al.. (2022). Alteplase Dose Assessment for Pleural infection Therapy (ADAPT) Study‐2: Use of 2.5 mg alteplase as a starting intrapleural dose. Respirology. 27(7). 510–516. 17 indexed citations
8.
Bedawi, Eihab O., Parthipan Sivakumar, Katie Ferguson, et al.. (2022). The impact of the COVID-19 pandemic on pleural infection incidence: a UK multicentre retrospective analysis. ERJ Open Research. 8(3). 206–2022. 2 indexed citations
9.
Wu, Zhe, Winston Banya, Nazia Chaudhuri, et al.. (2022). PAciFy Cough—a multicentre, double-blind, placebo-controlled, crossover trial of morphine sulphate for the treatment of pulmonary Fibrosis Cough. Trials. 23(1). 184–184. 9 indexed citations
10.
Myall, Katherine, et al.. (2022). How COVID-19 interacts with interstitial lung disease. Breathe. 18(1). 210158–210158. 9 indexed citations
11.
Myall, Katherine, Bhashkar Mukherjee, Giulia Benedetti, et al.. (2021). Persistent Post–COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment. Annals of the American Thoracic Society. 18(5). 799–806. 264 indexed citations breakdown →
12.
Myall, Katherine, et al.. (2021). Identifying patients at risk of post-discharge complications related to COVID-19 infection. Thorax. 76(4). 408–411. 34 indexed citations
13.
Walker, Steven, Oliver Bintcliffe, Emma Keenan, et al.. (2021). Randomised trial of indwelling pleural catheters for refractory transudative pleural effusions. European Respiratory Journal. 59(2). 2101362–2101362. 21 indexed citations
14.
Halford, Paul, Rahul Bhatnagar, Paul White, et al.. (2020). Manometry performed at indwelling pleural catheter insertion to predict unexpandable lung. Journal of Thoracic Disease. 12(4). 1374–1384. 6 indexed citations
15.
Walker, Steven, Emma Keenan, Oliver Bintcliffe, et al.. (2020). Ambulatory management of secondary spontaneous pneumothorax: a randomised controlled trial. European Respiratory Journal. 57(6). 2003375–2003375. 18 indexed citations
16.
Sivakumar, Parthipan, et al.. (2019). Multidisciplinary approach to connective tissue disease (CTD) related pleural effusions: a four-year retrospective evaluation. BMC Pulmonary Medicine. 19(1). 161–161. 6 indexed citations
17.
Noorzad, Farinaz, et al.. (2018). M24 Non-expandable lung in malignant pleural effusions at medical thoracoscopy. A259.1–A259. 1 indexed citations
19.
Haydar, Ali, Mark Denton, Alex West, John Rees, & David Goldsmith. (2003). Sirolimus-Induced Pneumonitis: Three Cases and a Review of the Literature. American Journal of Transplantation. 4(1). 137–139. 53 indexed citations
20.
Bajanowski, Thomas, Alex West, & B. Brinkmann. (1998). Proof of fatal air embolism. International Journal of Legal Medicine. 111(4). 208–211. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026